Table 2.

The proportion of controls with evidence of infection with HPV, stratified by age, sex and HIV serostatus

	All HPV	Genital HPV	Cutaneous-HPV
Age
15–28	27% (3/11)	27% (3/11)	9% (1/11)
29–32	33% (3/9)	33% (3/9)	0% (0/9)
33–70	56% (5/9)	56% (5/9)	0% (0/9)
Sex
Male	29% (4/14)	29% (4/14)	0% (0/14)
Female	47% (7/15)	47% (7/15)	7% (1/15)
HIV serostatus
Negative	32% (6/19)	32% (6/19)	0% (0/19)
Positive	50% (5/10)	50% (5/10)	10% (1/10)
TOTAL	38% (11/29)	38% (11/29)	3% (1/29)

None of the apparent differences in prevalence of HPV by age, sex or HIV sero-status was statistically significant.